Literature DB >> 20053139

Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial.

Catherine M Kelly1, Aman U Buzdar.   

Abstract

Entities:  

Year:  2010        PMID： 20053139     DOI： 10.1517/14656560903501551

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  2 in total

Review 1.  Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approval.

Authors:  Martin H Cohen; John R Johnson; Robert Justice; Richard Pazdur
Journal:  Oncologist       Date:  2011-11-16

2.  Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study.

Authors:  Xue Wang; Anjie Zhu; Jiayu Wang; Fei Ma; Jing Liu; Ying Fan; Yang Luo; Pin Zhang; Qing Li; Binghe Xu; Peng Yuan
Journal:  Ther Adv Med Oncol       Date:  2020-05-26       Impact factor: 8.168
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.